Crescent Biopharma Announces Trial In Progress Presentation For ASCEND Study Of CR-001, At ASCO 2026 Annual Meeting; Multiple CR-001 Clinical Data Readouts Anticipated Beginning In Q1 2027
Crescent Biopharma Inc CBIO
$20.66
▼ -3.77%
($-0.81)
Open
$21.41
Prev Close
$21.47
Day Range
$20.04 – $22.52
52W Range
$8.72 – $27.41
Market Cap
$569.36M
Beta
1.19
EPS (TTM)
$-12.33
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-01-10 |
| Shares Out. | 27,570,000 |
| Website | crescentbiopharma.com/ ↗ |
| Phone | 16174305595 |
Crescent Biopharma Inc is a publicly traded company under the ticker symbol CBIO on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-05-01)